Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2021-10-26 | "Mr. Sender is a senior executive and board member with more than 25 years of financial leadership experience at both large, multi-national pharmaceutical and early-stage biotechnology companies." |
| 2022-05-24 | Gary Sender(3) ... Includes 119,140 shares of Common Stock underlying options that will vest within 60 days of May 12, 2022 or will be fully vested within sixty days of May 12, 2022. |
| 2022-10-26 | "Mr. Sender is a senior executive and board member with more than 25 years of financial leadership experience ... Mr. Sender received a B.S. in Finance ... and an M.B.A." |
| 2023-10-26 | "Mr. Sender is a senior executive and board member with more than 25 years of financial leadership experience..." and "Mr. Sender received a B.S. in Finance from Boston University and an M.B.A. from Carnegie-Mellon University." |
| 2024-10-10 | "Mr. Sender is a senior executive and board member with more than 25 years of financial leadership experience... Mr. Sender received a B.S. in Finance..." |
Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-04-25